Related Experiment Video
Updated: Jan 5, 2026

07:05
In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
Published on: November 28, 2017
10.3K
Seasonal Inactivated Influenza Vaccination in Oncology Settings
N O’Callaghan1, T Hanan2, L Mullen2
1Department of Public Health, HSE Midlands
Irish Medical Journal
|October 25, 2019
Summary
Seasonal influenza vaccine uptake was 48% among oncology healthcare workers (HCWs) in 2016/17. Key barriers included fear of side-effects and doubts about vaccine effectiveness, despite most HCWs recommending the vaccine to patients.
Area of Science:
- Oncology
- Infectious Disease Epidemiology
- Occupational Health
Background:
- Healthcare workers (HCWs) play a critical role in preventing influenza transmission.
- Vaccination of HCWs is recommended to protect vulnerable cancer patients.
- Understanding HCW vaccination rates and influencing factors is crucial for public health initiatives.
Purpose of the Study:
- To determine the seasonal influenza vaccine uptake rate among oncology HCWs.
- To identify factors associated with or predicting vaccination in this cohort.
- To assess the implementation of national guidance on influenza vaccination for cancer patients.
Main Methods:
- A national cross-sectional study design was employed.
- Data were collected from clinical staff working in oncology day wards.
- Statistical analysis was used to identify predictors of vaccination.
Main Results:
- Influenza vaccine uptake among oncology HCWs was 48% for the 2016/17 season.
- Negative predictors of vaccination included fear of side-effects, perceived lack of need in healthy individuals, and skepticism about vaccine effectiveness.
- A high proportion of staff (87.6%) recommended influenza vaccination to their patients.
Conclusions:
- Targeted interventions are needed to increase influenza vaccination rates among oncology HCWs.
- Addressing concerns about vaccine safety and effectiveness is essential.
- Empowering HCWs to recommend vaccination is vital for patient protection.
Related Concept Videos
Cancer Vaccines
910
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
910
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Vaccinations
51.0K
Overview
51.0K
Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Pneumonia V: Nursing management and Prevention
3.3K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.3K

